Indication
Gastrointestinal Disease
4 clinical trials
5 products
1 drug
Product
PralsetinibClinical trial
A Phase 1/2 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid TumorsStatus: Completed, Estimated PCD: 2024-03-21
Product
PBK_M2101Clinical trial
A Prospective, Randomized, Parallel, Multi-center, Phase 3 Trial to Evaluate Safety and Efficacy of PBK_M2101Status: Recruiting, Estimated PCD: 2024-05-01
Product
Oral Sulfate TabletClinical trial
A Feasibility Study of SGM-101, a Fluorochrome-labeled Anti-carcinoembryonic Antigen Monoclonal Antibody for the Intraoperative Detection of Colorectal Brain Metastases.Status: Recruiting, Estimated PCD: 2026-02-01
Product
SGM-101Clinical trial
A Study to Assess Sedation Using Intranasal Dexmedetomidine in Upper Gastrointestinal EndoscopyStatus: Completed, Estimated PCD: 2010-03-01
Product
DexmedetomidineDrug
Varlilumab